Clinical trial
Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies
NCT05827198 is registered in ClinicalTrials.gov with Mondelēz International, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Candies
- Lead sponsor
- Mondelēz International, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 12, 2023
- Completion date
- January 27, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal tolerance, healthy population